EC Number   |
Inhibitors |
Structure  |
|---|
    1.14.14.154 | more |
no inhibition by 24,28-dihydroobtusifoliol |
 |
| 1.14.14.154 | more |
in vivo inhibition study with different strains, overview |
|
| 1.14.14.154 | more |
the enzyme is highly resistant to triadimenol |
|
| 1.14.14.154 | more |
Oculimacula acuformis is intrinsically resistant to triazoles and sensitive to imidazoles |
|
| 1.14.14.154 | more |
14alpha-carboaldehyde reaction intermediates are effective in competitive enzyme inhibition and as hypocholesterolemic agents |
|
| 1.14.14.154 | more |
design of non-azole antifungal lead compounds based on the constructed three-dimensional model of CYP51by coupling structure-based de novo design, overview |
|
| 1.14.14.154 | more |
inhibitory potency, antifungal activity in vivo, and structure-function analysis of 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[(4-substituted phenyl)-piperazin-1-yl]-propan-2-ol derivatives, overview |
|
| 1.14.14.154 | more |
inhibition kinetics and mechanism |
|
| 1.14.14.154 | more |
inhibitory potency of fungicides, antifungal drugs, and cytostatic drugs, overview |
|
| 1.14.14.154 | more |
specific inhibitor screening |
|
